miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
about
miRNAs as potential biomarkers in early breast cancer detection following mammographyMicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy EfficacyMicroRNA in breast cancer: The association with BRCA1/2.Serum MicroRNA profile in patients with colon adenomas or cancer.Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancerEvaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancersMiR-300 regulate the malignancy of breast cancer by targeting p53.MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survivalMitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancerMicroRNA analysis of breast ductal fluid in breast cancer patients.Effect of the BRCA1-SIRT1-EGFR axis on cisplatin sensitivity in ovarian cancer.miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cellsMicroRNAs differentially expressed in Behçet disease are involved in interleukin-6 production.A Point Mutation in DNA Polymerase β (POLB) Gene Is Associated with Increased Progesterone Receptor (PR) Expression and Intraperitoneal Metastasis in Gastric Cancer.MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.miR-638 suppresses DNA damage repair by targeting SMC1A expression in terminally differentiated cellsDownregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.MicroRNA expression in bone marrow-derived human multipotent Stromal cells.Role of ARPC2 in Human Gastric Cancer.Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance.IQ-domain GTPase-activating protein 1 promotes the malignant phenotype of invasive ductal breast carcinoma via canonical Wnt pathway.Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.MiRNAs-mediated cisplatin resistance in breast cancer.MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma.Hsa-miR-520d-5p promotes survival in human dermal fibroblasts exposed to a lethal dose of UV irradiation.Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer.The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation.Prenatal phthalate exposure and altered patterns of DNA methylation in cord blood.The Bioactivity of D-/L-Isonucleoside- and 2'-Deoxyinosine-Incorporated Aptamer AS1411s Including DNA Replication/MicroRNA Expression.MiR-638 acts as a tumor suppressor gene in gastric cancer.A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer.Pattern-based sensing of triple negative breast cancer cells with dual-ligand cofunctionalized gold nanoclusters.Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.Expression of microRNA 638 and sex-determining region Y-box 2 in hepatocellular carcinoma: Association between clinicopathological features and prognosis.MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in NumbersDownregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients
P2860
Q26773094-C8783CFA-B4BA-4DB5-ACCD-53347934EE0FQ28829013-F5957E39-C763-4A15-AFC6-9F26958D6BE7Q33364654-F82D6D58-0F75-4E79-8712-352701DB196DQ33587284-9F2E1A52-5755-40FE-BCE1-C82A5AF02A0CQ33838622-31A65478-533C-4772-8064-C13F4B7A6C5EQ34785511-BA372719-4E30-4488-8CD3-76E393560F2DQ35816698-D5409545-E20C-402E-9525-DBF27C930793Q35870648-B4FADD26-5E64-4351-AB47-DECF5A686F7EQ35919084-AB7B25FB-95A4-487F-A043-BF3C4153FC7BQ35958353-22619977-C304-4737-9804-CBC729931722Q36020872-75E5A490-65FB-4E88-8147-97159AD5EDF8Q36729390-6CA5052A-938D-451F-8663-F7F6FD1E8EDEQ36734184-DC354B17-F7B4-437A-99F0-2A401609009DQ36878642-443A12EE-DC10-4CCE-A6C0-C58B4DDFDA8DQ37109827-82CFAB21-0834-4419-91EB-98DC74EF2B94Q37111357-9DBAF316-1C5A-4285-9D25-A2C6785F1F19Q37133659-C783F5AF-100C-49CA-A4D1-7CBD55ADCF32Q37190254-823FB25A-9DF7-4810-8372-EE58C99AE47EQ37194235-EDBF3C37-BAD1-40D0-84B3-2713804937CDQ37327584-0263070A-EB8F-4B86-916B-4FAB6367FE13Q38628576-325E6F1D-F880-4253-BDBC-B189CD6D1A04Q38697602-0DD5AE9E-67CF-4D17-A4BD-BC553BB36AD2Q38702727-26FAEA30-72F1-447C-852E-965239847BDFQ38723812-5C8A9A61-8035-4DA8-AC82-5F6D401FD6ABQ38812088-2017237A-0036-4672-8B51-39280A2AECD1Q38905681-0674668E-9E90-4BE9-B302-ACB973461184Q39455098-3F13EA58-2224-4D45-8E7F-611308077EF8Q40117584-976EDC4C-94D9-4FE5-A254-86738600FCC6Q40700592-343E42C4-BE71-4877-92AF-5D829BBC3856Q42368096-67B181A0-C21A-4DC4-AD82-59B229145EFFQ46513323-FCBE1A8A-0638-4AF1-8CA5-80E767CEDE3FQ47105275-49DEE37A-BA57-41FA-B181-C913DACDE116Q47133047-7A31C737-BA77-46CA-B00B-349C773316CCQ47293862-D2E8BDAE-328B-4B9A-BC4D-9C10403C897AQ49754519-B0439825-D80C-41F6-BEF9-A01D01D1EA83Q52648392-6195DE9E-AEDD-406E-9728-BEE8FFB8F352Q54995147-63E7A3CF-539B-405B-86AB-2A797A14F8DFQ57106460-E5E6E5E4-7847-4C50-AD38-BC458A295CF6Q57815594-FE1B1DE0-A9DD-4C9E-850E-251C26B0B18B
P2860
miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
miR-638 mediated regulation of ...... triple-negative breast cancer.
@ast
miR-638 mediated regulation of ...... triple-negative breast cancer.
@en
type
label
miR-638 mediated regulation of ...... triple-negative breast cancer.
@ast
miR-638 mediated regulation of ...... triple-negative breast cancer.
@en
prefLabel
miR-638 mediated regulation of ...... triple-negative breast cancer.
@ast
miR-638 mediated regulation of ...... triple-negative breast cancer.
@en
P2093
P2860
P1476
miR-638 mediated regulation of ...... triple-negative breast cancer.
@en
P2093
Christine B Teal
Katayoon Rezaei
Rachel F Brem
Sana Tabbara
Shejuan An
Sidney W Fu
Xiaohui Tan
Yan-gao Man
P2860
P2888
P356
10.1186/S13058-014-0435-5
P577
2014-09-17T00:00:00Z
P5875
P6179
1040671870